Status:
COMPLETED
Monitoring of the Inflammatory Response of Patients With Premature Rupture of Membranes With Bedside Tests
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Premature Rupture of Fetal Membranes
Eligibility:
FEMALE
18-40 years
Brief Summary
Prematurity represents 8% of birth and it is one of the leading causes of infant complications. The preterm premature rupture of membranes (PPROM) represents one-third of preterm birth and the rupture...
Detailed Description
Preterm premature rupture of the membranes (PPROM) represents one-third of preterm births and is the leading cause of perinatal mortality and morbidity. During the latency period, several events such ...
Eligibility Criteria
Inclusion
- Women with a single fetus and hospitalized for a rupture of membranes at term or before term.
- The criteria for diagnosis of rupture of membranes is based on clinical and biochemical tests, including Fern test and Actim PROM test
Exclusion
- Twin pregnancies, patients in labor, the presence of medical complications which exclude expectant management including abruptio placentae, preeclampsia or eclampsia and fetal death.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00940043
Start Date
September 1 2008
End Date
December 1 2009
Last Update
January 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier de l'Université de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4